Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Oct 06, 2021 10:34am
154 Views
Post# 33973253

RE:RE:RE:I’m bullish.

RE:RE:RE:I’m bullish.Lmao being wrong and lying are 2 different things. One the other hand you have lied about:

1-clinical staging
2-any shares you own 
3-interpretation of the AME NR as “last nail in the coffin” 
4-called this company “not a real investment”

the list goes on. And multiple people have called you out. 

And you claim to have proved yourself by posting an unsolicited pic of daddy’s car? Lmao. We want a screenshot of shares or stfu. 


Rarbar99 wrote:

Remember when you lied and said $4 is a good entry price back in June 2021?

I've already proven myself, it's your turn.

Inthepez wrote: Remember when ratbar99 lied said he was bullish lmao!!

We still have yet to see a screenshot of those shares you claim to own. ;)  
 

 

Rarbar99 wrote: I was bearish when this was in the 1.40-1.55 range, and as I predicted, it dropped back to the low 1s just a week later.

but yesterday, after some more research, I clearly stated that I'm a bull now.

I do believe in this company and will hold my shares, even if they eventually go bankrupt and this stock goes to $0

i Won't buy anymore shares until October though. I want to see a little more stabilization before I start investing serious cash into this.

 




<< Previous
Bullboard Posts
Next >>